Copyright
©2012 Baishideng Publishing Group Co.
World J Diabetes. Jan 15, 2012; 3(1): 7-18
Published online Jan 15, 2012. doi: 10.4239/wjd.v3.i1.7
Published online Jan 15, 2012. doi: 10.4239/wjd.v3.i1.7
Table 1 Mechanisms and consequences related to protein kinase C activation-mediated harmful effects in diabetes mellitus
| Reduction of nitric oxide production |
| Increased endothelin-1, prostaglandin E2 and thromboxane A2 |
| Induction of growth factor expression: Transforming growth factor-β and vascular endothelial growth factor |
| Accumulation of microvascular matrix, fibronectin and type IV collagen |
| Overexpression of fibrinolytic inhibitor plasminogen activator inhibitor-1 |
| Activation of the transcription factor nuclear factor kappa B |
| Increased nicotinamide adenine dinucleotide phosphate oxidase activity |
| Blood-flow abnormalities |
| Alteration of vascular permeability |
| Induction of angiogenesis |
| Organ fibrosis |
| Capillary occlusion |
| Induction of inflammatory mediators |
| Stimulation of oxidative stress |
Table 2 Inflammatory cytokine-related effects potentially involved in the development and progression of renal injury in diabetes
| Increase expression and synthesis of chemokines, adhesion molecules, transcription factors, cytokines, growth factors and mediators of inflammation |
| Alteration of synthesis of prostaglandins and hyaluronan |
| Stimulation of oxidative stress |
| Induction of intraglomerular hemodynamic abnormalities |
| Increase of vascular endothelial cell permeability |
| Induction of cell proliferation and contraction, and inhibition of endothelium relaxation |
| Increase fibronectin expression |
| Induction of cell apoptosis and necrosis |
| Induction of glomerular hypertrophy |
| Stimulation of plasminogen activator inhibitor-1 production |
| Reduction of tissue factor inhibitor and thrombomodulin expression |
| Stimulation of inflammatory cells recruitment and activation |
| Induction of major histocompatibility complex antigen expression |
- Citation: Luis-Rodríguez D, Martínez-Castelao A, Górriz JL, Álvaro F, Navarro-González JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes 2012; 3(1): 7-18
- URL: https://www.wjgnet.com/1948-9358/full/v3/i1/7.htm
- DOI: https://dx.doi.org/10.4239/wjd.v3.i1.7
